A Paradigm Shift in Nonalcoholic Fatty Liver Disease Management – 1 CE – Live Webinar on October 11, 2021 10AM ET
Pharmacist Learning Objectives
At the conclusion of this continuing education activity, the participant will be able to:
- Recognize the associated burden of disease due to non-alcoholic liver disease (NAFLD) in adult patients
- Discuss the pathophysiology and clinical presentation of NAFLD
- Review current national guideline recommendations for the treatment of patients with NAFLD
- Evaluate recent literature on emerging treatment options and the real-world application for the management of NAFLD patients
AchieveCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
AchieveCE is also accredited by the Florida Board of Pharmacy (provider no. 50-20641). This course is approved by CE Broker, with CE Broker No. 20-882588.
Erenie Guirguis, Phar
Financial Support Disclosure
This activity was developed by AchieveCE free of any commercial support. Erenie Guirguis, Phar
Level 2. Basic Application of Skills and Concepts
1.0 Contact Hour
October 11, 2021 (Mon)
10AM Eastern Time
Universal Activity Number
Activity Release Date
September 30, 2021
Activity Expiration Date
September 30, 2024
Requirements for Credit
Participants must correctly enter the 4-digit evaluation access code provided into the test at the conclusion of the webinar and complete an activity evaluation. Credits will be reported automatically to CE Broker if your license information is entered properly in your profile.
Windows 8.1, Windows 10
Mac OS X 10.1 or higher
iOS 10+, Android 4.3+
Google Chrome, Microsoft Edge, Mozilla Firefox
Adobe Acrobat Reader
Broadband Internet Connection:
T1, Hi-speed DSL or Cable
4G cellular connection
Ready to Start?
You may also be interested in: